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INTRODUCTION
Acute myocardial infarction (MI) is one
of the leading causes of mortality world-
wide. MI is the heart muscle irreversible
death secondary to prolonged ischemia.
Over the last few decades, medical progress
in how and when to restore blood
flow to the ischemic area have markedly
improved patient survival. Although early
heart reperfusion is acknowledged to be
the most effective way to limit infarct
size, post-ischemic reperfusion is asso-
ciated with detrimental effects, such as
myocardial stunning, ventricular arrhyth-
mias, microvascular dysfunction, and cell
death. The molecular mechanisms of these
reperfusion injuries remain to be elu-
cidated and their management is very
challenging.
Among the various therapeutic molec-
ular approaches proposed by experimental
studies, nitric oxide (NO) role in pro-
tecting heart against MI and reperfusion
injuries has been widely assessed and dis-
cussed (1–4). NO is a gasotransmitter
that is abundantly produced in the car-
diovascular system mainly by the NO
synthase (NOS) enzymes system. Two
isoforms, endothelial NOS (eNOS) and
neuronal NOS (nNOS), are constitutively
expressed in both myocardium and vessels,
whereas inducible NOS (iNOS) is detected
only in pathological conditions, such as
inflammatory and/or oxidative stress. Both
eNOS and nNOS are low-NO output
Ca2+-dependent enzymes, while iNOS
is a high-NO output Ca2+-independent
enzyme. In physiological conditions, NOS
form homodimers (“coupled” NOS) that
catalyze NO production from l-arginine
and O2 through electron transfer from
NADPH on the reductase domain of one
monomer to the oxidase domain of the sec-
ond monomer. In pathological conditions,
such as in the absence of the essential cofac-
tor tetrahydrobiopterin (BH4), eNOS can
be “uncoupled” to produce O2− instead
of NO.
In stress conditions, NO protects tis-
sues through two distinct pathways. In
the first one, NO activates the soluble
guanylate cyclase (sGC) that initiates cyclic
guanosine monophosphate (cGMP) pro-
duction, leading to the activation of pro-
tein kinase G (PKG). As sGC is the
major cell receptor for NO and the
NO/sGC/cGMP/PKG pathway plays a crit-
ical role in both myocardium excitation–
contraction coupling and cardiovascular
function regulation (5–8), NO cardiopro-
tective role was first attributed to PKG
activation (9–11). However, a second path-
way in which proteins are directly modified
by NO addition to sulfhydryl residues, a
process known as S-nitrosylation (SNO),
has recently emerged in the scientific lit-
erature. Although PKG activation path-
way has been largely involved in NO-
mediated cardioprotection (11–13), SNO
is now taking the front stage and is con-
sidered to be a key player in cardiopro-
tection through (i) the transient mod-
ification of protein activity and/or (ii)
their protection from irreversible oxida-
tion (14–17). Indeed, Sun et al. (18)
showed that reduced heart vulnerability to
ischemia–reperfusion (IR) following acute
ischemic preconditioning is mainly related
to SNO signaling and not to PKG activa-
tion through the NO–SGC–cGMP path-
way. Accordingly, we found that in exercise
training-induced cardioprotection against
IR injuries, protein SNO level, but not
cGMP level, increased during early reper-
fusion (19). The same year, Methner et al.
(20), using a Cre/loxP approach to selec-
tively ablate type I PKG in cardiomy-
ocytes, demonstrated that ischemic post-
conditioning reduced infarct size in these
mice like in wild type controls. More-
over, they showed that the cardioprotective
effect against IR injury of mitochondria-
targeted S-nitrosothiol (MitoSNO), which
allows NO and S-nitrosothiol accumula-
tion in mitochondria, was comparable in
mice that specifically lack PKG in car-
diomyocytes and in controls. This indi-
cates that MitoSNO cardioprotective effect
is independent of PKG.
The current literature strongly supports
NO implication in cardioprotection. How-
ever, the mechanism is still debated and
whether increased NO availability during
IR is cytoprotective remains to be demon-
strated. Here, we discuss how NO might
contribute to protect heart and particularly
the importance of NO (i) localization, (ii)
concentration, and (iii) time of availability
during IR.
RIGHT PLACE
NO signaling depends on NOS cardiomy-
ocyte subcellular localization (8, 21).
Indeed, eNOS-catalyzed NO production
occurs almost everywhere in the cell, thus
leading to SNO of many targets (mem-
brane and cytosolic proteins). On the other
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hand, nNOS colocalizes with SERCA and
RyR and is associated with SNO mainly
of reticulum sarcoplasmic proteins (16,
22). Although more than 1000 proteins
are S-nitrosylated in hearts, recent findings
suggest that cardiac mitochondrial proteins
are key targets of NO-dependent cardio-
protection. For instance, Sun et al. (23)
reported that during ischemic precondi-
tioning,caveolae-mediated transduction of
eNOS/NO/SNO signaling to end-effector
mitochondria leads to cardioprotection.
Recently, Chouchani et al. (24) elegantly
demonstrated that MitoSNO-induced
heart protection could be explained by
SNO of the ND3 subunit of mitochondrial
complex I (on Cys39) to transiently lock it
in a low-activity state, thus decreasing ROS
production during early reperfusion. This
SNO of the ND3 subunit was observed
using an ischemic preconditioning exper-
imental approach. Thus, through SNO,
NO could directly protect mitochondr-
ial proteins during IR. However, NO has
also indirect effects. Indeed, Huang et al.
(25) reported that SNO of G-protein-
coupled receptor kinase 2 (GRK2) is the
primary target of NO cardioprotective
activity. Although GRK2 is a cytosolic
protein that regulates the activity of G-
protein coupled receptors, the authors
found that, during IR, GRK2 translocates
to mitochondria and activates the cell
death pathway. SNO-dependent inhibi-
tion of GRK2 could then have a protective
effect, mainly by preserving mitochondrial
integrity.
S-nitrosylation clearly has beneficial
effects during IR when targeting specif-
ically mitochondria; however, incorpora-
tion of a NO moiety (NO+ or NO) to
a sulfur atom can also be deleterious.
Indeed, hypernitrosylation of RyR2 chan-
nels via the TNF-α/caspase 8 pathway
increases Ca2+ leak from the sarcoplas-
mic reticulum (SR), thus contributing to
cell death during IR (26). In this work,
reduction of RyR2-SNO by using a cas-
pase 8 inhibitor (Q-LETD-OPh) reduced
infarct size in mice. On the other hand,
RyR2 hyponitrosylation also promotes
SR Ca2+ leak and thus might increase
heart vulnerability to IR (27). Based on
these results, Beigi et al. (28) demon-
strated that dynamic SNO/denitrosylation
reactions are essential for cardiovascular
homeostasis.
Taken together, these data clearly show
that SNO plays a key role in cardioprotec-
tion and also illustrate that this positive
effect depends on the target and thus on
the subcellular localization of NO synthe-
sis. NO concentration could also be impor-
tant and seems to be directly linked to the
cellular redox state during IR (4). Indeed,
although NO has undoubtedly a cardio-
protective function, it could go over to the
dark side, particularly if too much NO is
produced or if it is available at the wrong
moment.
RIGHT CONCENTRATION
In pro-oxidative conditions, such as during
myocardial IR, NO can react with O2− to
form peroxynitrite (ONOO−), a cytotoxic
molecule that is considered to be the main
trigger of reperfusion injuries (29). Con-
sequently, it is debated whether increasing
NO bioavailability during IR has a cardio-
protective effect (30). For instance, NOS
overexpression, BH4 supplementation, or
nitrite supplementation reduces heart sen-
sitivity to IR (31–34). Also, numerous stud-
ies showed the cytoprotective function of
iNOS during the specific late phase of pre-
conditioning (35). But conversely, Csonka
et al. (36) demonstrated that classical
preconditioning induces cardioprotection
by reducing NO harmful accumulation
during early reperfusion. Consistently,
the group of Zweier suggested that, in
a pro-oxidative environment, transient
limitation of NO synthesis via tempo-
rary S-gluthationylation-mediated NOS
uncoupling might exert a cardioprotective
effect by limiting ONOO− overproduction
(37, 38). Similarly, we demonstrated that
exercise-induced cardioprotection requires
eNOS uncoupling during early reperfu-
sion to limit excessive NO production and
thus to reduce nitro-oxidative stress (19).
If eNOS uncoupling during IR is cor-
rected by BH4 supplementation, higher
ONOO− production and increased infarct
size are observed (19). Nonetheless, in this
rat model of cardioprotection, reduced NO
synthesis due to eNOS uncoupling dur-
ing early reperfusion was counterbalanced
by increased storage of NO metabolites
(nitrite and S-nitrosothiols) in hearts of
exercised rats (compared to sedentary con-
trols). This allowed maintaining a high
level of protein SNO, and thus of cardio-
protection, during early reperfusion.
NO availability could mostly explain the
discrepant findings concerning the effects
of increasing or reducing NO synthesis
during IR.
RIGHT TIME
The time of NO availability for SNO
of key proteins during IR seems to be
critical. Recently, Chouchani et al. (24)
showed that SNO of mitochondrial com-
plex I by MitoSNO can be observed only
after ischemia and does not occur in nor-
moxic hearts. The authors suggested that
ischemia allows the exposure of Cys39
in the ND3 subunit of complex I for
SNO. Considering that this mechanism
is a key point of SNO-dependent car-
dioprotection, we can hypothesize that
any strategy to make NO available dur-
ing the ischemic period could contribute
to protect the myocardium during IR.
However, during ischemia, eNOS is not
functional because it is monomerized,
its activation by phosphorylation blunted
(19) and its substrates (especially O2)
are lacking. Therefore, NO availability in
ischemic conditions is mainly dependent
on NO metabolites (i.e., nitrite and S-
nitrosothiols). Nitrite, a NO reservoir, is
reduced to NO during ischemia by nitrite
reductase (32) and S-nitrosothiols can
decompose to liberate NO (39). Thus,
oral treatment with nitrite (40) or acute
nitrite administration before ischemia (41)
increases NO metabolite storage, provid-
ing cardioprotection against IR. More-
over, nitrite therapy mediates cardiopro-
tection by modulating mitochondrial func-
tion, leading to increased SNO of the
ND3 subunit of the mitochondrial com-
plex I (24). We (19) and others (42),
showed that the beneficial effects of exer-
cise on IR injuries are mainly mediated
through the increase of the NO metabo-
lite reserve before ischemia. In our work,
such increase was associated with higher
protein SNO level during early reperfu-
sion. Finally, Calvert et al. (42) clearly
demonstrated, using mice in which β3-
adrenergic receptor (which plays a key
role in eNOS activation) was knocked
out that inhibition of exercise-induced
NO metabolite storage increase abolishes
the cardioprotective effects of exercise
against IR.
Altogether, these results indicate that
ensuring NO availability during the
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ischemic period by increasing NO metabo-
lites storage and improving SNO during
early reperfusion are key steps for efficient
cardioprotection.
CONCLUSION
NO is essential to limit the deleteri-
ous effects of post-ischemic reperfusion.
Experimental studies indicate that NO
exerts its cardioprotective effect against
ischemia–reperfusion injuries not only
directly through protein SNO but also indi-
rectly through the NO/GCs/GMPc/PKG
signaling pathway. Among the many cel-
lular targets of NO, SNO of mitochon-
drial proteins during IR seems to play a
key role. However, the efficiency of NO-
induced cardioprotection depends on (i) its
concentration, because NO can also gen-
erate nitro-oxidative stress (through the
formation of ONOO−), (ii) its subcellular
localization, and (iii) when it is available.
Thus, improving NO metabolite (nitrites
and S-nitrosothiols) storage before and
during ischemia, to optimize NO availabil-
ity and SNO during ischemia and early
reperfusion, is an efficient strategy. Never-
theless, further studies are needed to bet-
ter understand NO metabolism dynamics
during IR in order to liberate the right
amount of NO in the right place and at
the right time.
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